Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis-Reference-Cited by-同舟云学术

Quantitatively Excessive Normal Tissue Toxicity and Poor Target Coverage in Postoperative Lung Cancer Radiotherapy Meta-analysis

Published:2018-01 Issue:1 Volume:19 Page:e123-e130
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Abuodeh Yazan,Naghavi Arash O.,Echevarria Michelle,DeMarco MaryLou,Tonner Brian,Feygelman Vladimir,Stevens Craig W.,Perez Bradford A.,Dilling Thomas J.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Cancer Facts and Figures, 2016,2016

2. Postoperative radiotherapy in non–small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group;Lancet,1998

3. Postoperative radiotherapy for stage II or III non–small-cell lung cancer using the Surveillance, Epidemiology, and End Results database;Lally;J Clin Oncol,2006

4. Postoperative radiotherapy in non–small-cell lung cancer warrants further exploration in the era of adjuvant chemotherapy and conformal radiotherapy;Bonner;J Clin Oncol,2006

5. The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database;Lally;Cancer,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer—A Review;Cancers;2022-03-23

2. Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non–small-cell Lung Cancer;Clinical Lung Cancer;2021-09

3. Radiotherapy: An Alternative to Surgery;Lung Cancer - Modern Multidisciplinary Management;2021-06-02

4. Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question;Translational Lung Cancer Research;2021-04